Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma

Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adju...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of orthopaedic and trauma surgery 1998, Vol.117 (1-2), p.43-46
Hauptverfasser: QUINT, U, MÜLLER, R. T, MÜLLER, G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 46
container_issue 1-2
container_start_page 43
container_title Archives of orthopaedic and trauma surgery
container_volume 117
creator QUINT, U
MÜLLER, R. T
MÜLLER, G
description Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.
doi_str_mv 10.1007/BF00703438
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00703438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9457335</sourcerecordid><originalsourceid>FETCH-LOGICAL-c202t-a794e2d6510d4205e09c6b33b484a4b1c93de619460c50d5279d8352d96dbf1c3</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMo67p68S7k4EmsTj7beNPFj4UFL3ouaZKylbRZki6ov96WLSsMM7wzzwzMi9AlgTsCkN8_vQwZGGfFEZoTznjGFJHHaA6KyawAQU7RWUpfAIQWCmZoprjIGRNz9Lvc6KhN72KT-sYkHGq83bguePyAV93Q8173TehwM0YftXdpkNrjfteGiN23acbGuGg2obMxVF6nPrT6FofUu2AmiXVnsesmqNXn6KTWPrmLqS7Q58vzx_ItW7-_rpaP68xQoH2mc8UdtVIQsJyCcKCMrBireME1r4hRzDpJFJdgBFhBc2ULJqhV0lY1MWyBbvZ3TQwpRVeX29i0Ov6UBMrRv_LfvwG-2sPbXdU6e0Anw4b59TTXyWhfR90N_x8wCnnOZM7-AOgseVU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>QUINT, U ; MÜLLER, R. T ; MÜLLER, G</creator><creatorcontrib>QUINT, U ; MÜLLER, R. T ; MÜLLER, G</creatorcontrib><description>Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.</description><identifier>ISSN: 0936-8051</identifier><identifier>EISSN: 1434-3916</identifier><identifier>DOI: 10.1007/BF00703438</identifier><identifier>PMID: 9457335</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adult ; Biological and medical sciences ; Bone Neoplasms - surgery ; Bones, joints and connective tissue. Antiinflammatory agents ; Chondroblastoma - surgery ; Chondroma - surgery ; Combined Modality Therapy ; Female ; Giant Cell Tumor of Bone - surgery ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Phenol - administration &amp; dosage ; Phenol - pharmacokinetics ; Phenol - urine ; Prospective Studies ; Therapeutic Irrigation</subject><ispartof>Archives of orthopaedic and trauma surgery, 1998, Vol.117 (1-2), p.43-46</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c202t-a794e2d6510d4205e09c6b33b484a4b1c93de619460c50d5279d8352d96dbf1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2077367$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9457335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>QUINT, U</creatorcontrib><creatorcontrib>MÜLLER, R. T</creatorcontrib><creatorcontrib>MÜLLER, G</creatorcontrib><title>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</title><title>Archives of orthopaedic and trauma surgery</title><addtitle>Arch Orthop Trauma Surg</addtitle><description>Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bone Neoplasms - surgery</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Chondroblastoma - surgery</subject><subject>Chondroma - surgery</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Giant Cell Tumor of Bone - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenol - administration &amp; dosage</subject><subject>Phenol - pharmacokinetics</subject><subject>Phenol - urine</subject><subject>Prospective Studies</subject><subject>Therapeutic Irrigation</subject><issn>0936-8051</issn><issn>1434-3916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LxDAQhoMo67p68S7k4EmsTj7beNPFj4UFL3ouaZKylbRZki6ov96WLSsMM7wzzwzMi9AlgTsCkN8_vQwZGGfFEZoTznjGFJHHaA6KyawAQU7RWUpfAIQWCmZoprjIGRNz9Lvc6KhN72KT-sYkHGq83bguePyAV93Q8173TehwM0YftXdpkNrjfteGiN23acbGuGg2obMxVF6nPrT6FofUu2AmiXVnsesmqNXn6KTWPrmLqS7Q58vzx_ItW7-_rpaP68xQoH2mc8UdtVIQsJyCcKCMrBireME1r4hRzDpJFJdgBFhBc2ULJqhV0lY1MWyBbvZ3TQwpRVeX29i0Ov6UBMrRv_LfvwG-2sPbXdU6e0Anw4b59TTXyWhfR90N_x8wCnnOZM7-AOgseVU</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>QUINT, U</creator><creator>MÜLLER, R. T</creator><creator>MÜLLER, G</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1998</creationdate><title>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</title><author>QUINT, U ; MÜLLER, R. T ; MÜLLER, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c202t-a794e2d6510d4205e09c6b33b484a4b1c93de619460c50d5279d8352d96dbf1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bone Neoplasms - surgery</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Chondroblastoma - surgery</topic><topic>Chondroma - surgery</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Giant Cell Tumor of Bone - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenol - administration &amp; dosage</topic><topic>Phenol - pharmacokinetics</topic><topic>Phenol - urine</topic><topic>Prospective Studies</topic><topic>Therapeutic Irrigation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>QUINT, U</creatorcontrib><creatorcontrib>MÜLLER, R. T</creatorcontrib><creatorcontrib>MÜLLER, G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Archives of orthopaedic and trauma surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>QUINT, U</au><au>MÜLLER, R. T</au><au>MÜLLER, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</atitle><jtitle>Archives of orthopaedic and trauma surgery</jtitle><addtitle>Arch Orthop Trauma Surg</addtitle><date>1998</date><risdate>1998</risdate><volume>117</volume><issue>1-2</issue><spage>43</spage><epage>46</epage><pages>43-46</pages><issn>0936-8051</issn><eissn>1434-3916</eissn><abstract>Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>9457335</pmid><doi>10.1007/BF00703438</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0936-8051
ispartof Archives of orthopaedic and trauma surgery, 1998, Vol.117 (1-2), p.43-46
issn 0936-8051
1434-3916
language eng
recordid cdi_crossref_primary_10_1007_BF00703438
source MEDLINE; SpringerNature Journals
subjects Adult
Biological and medical sciences
Bone Neoplasms - surgery
Bones, joints and connective tissue. Antiinflammatory agents
Chondroblastoma - surgery
Chondroma - surgery
Combined Modality Therapy
Female
Giant Cell Tumor of Bone - surgery
Humans
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Phenol - administration & dosage
Phenol - pharmacokinetics
Phenol - urine
Prospective Studies
Therapeutic Irrigation
title Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T23%3A46%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20of%20phenol%20:%20Instillation%20in%20intralesional%20tumor%20excision%20of%20chondroblastoma,%20osteoclastoma%20and%20enchondroma&rft.jtitle=Archives%20of%20orthopaedic%20and%20trauma%20surgery&rft.au=QUINT,%20U&rft.date=1998&rft.volume=117&rft.issue=1-2&rft.spage=43&rft.epage=46&rft.pages=43-46&rft.issn=0936-8051&rft.eissn=1434-3916&rft_id=info:doi/10.1007/BF00703438&rft_dat=%3Cpubmed_cross%3E9457335%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9457335&rfr_iscdi=true